Il-Dong Esomeprazole Magnesium Trihydrate 40 mg Tablet
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Il-Dong Pharmaceutical Co., Ltd.
MFDS item code 202003749 · Approved 2020.05.22
This product's status changed to Approval withdrawn on 2024.07.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment and prevention of reflux and acid-related disorders, Helicobacter pylori infection, ulcers and rebleeding, and gastrointestinal disorders caused by anti-inflammatory analgesics
This medication is used to treat gastroesophageal reflux disease and erosive reflux esophagitis, and it is also effective for long-term maintenance therapy to prevent recurrence in patients with esophagitis. It is also helpful in alleviating symptoms of gastroesophageal reflux disease without esophagitis. It is used in combination with antibiotics for the treatment and prevention of relapse in patients with duodenal ulcers and peptic ulcers associated with Helicobacter pylori infection. It is used short-term for the treatment of upper gastrointestinal symptoms related to the use of non-steroidal anti-inflammatory drugs, and is effective for the treatment and prevention of gastric ulcers and duodenal ulcers due to continuous use of non-steroidal anti-inflammatory drugs. It is also applied for maintenance therapy for Zollinger-Ellison syndrome and prevention of rebleeding from gastric and duodenal ulcers. Thus, it is widely used for the treatment and prevention of various gastrointestinal diseases.
1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Antibiotic combination therapy for Helicobacter pylori eradication Administer this drug 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug use (COX-2 nonselective or selective) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug therapy - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with a dose of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and administered twice daily. 6) Maintenance therapy after intravenous induction of prevention of rebleeding due to gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks after intravenous induction of prevention of rebleeding due to gastric or duodenal ulcers. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience with administration to patients with severe renal impairment. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this drug should not exceed 20 mg. 6. Older adults No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, subsequent recurring symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed use to control recurring symptoms is not recommended in patients at high risk of gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 3. Children under 12 years of age There is no experience with administration of this drug to children under 12 years of age.
This medication should not be administered to patients with specific allergic reactions. For example, patients who are allergic to this medication, its components, or benzimidazole derivatives, or who have previously experienced such reactions should avoid its use. Additionally, patients allergic to penicillin or macrolide antibiotics, which are used in conjunction for the eradication treatment of Helicobacter pylori, should also refrain from using this medication. Patients taking specific heart-related medications, such as terfenadine, cisapride, pimodine, or astemizole, should not use this medication in conjunction. Patients receiving antiviral drugs such as atazanavir or nelfinavir, nursing women, patients with a history of myocardial infarction, and patients taking rilpivirine should also avoid this medication. During the use of this medication, various adverse reactions may occur. Digestive symptoms such as headache, abdominal pain, diarrhea, nausea, and vomiting are frequently reported, and in rare cases, serious side effects such as blood abnormalities, skin rashes, liver dysfunction, and hypomagnesemia may occur. Particularly, long-term use may lead to hypomagnesemia, so it's important to regularly monitor magnesium levels in the blood. Additionally, because this medication suppresses gastric acid secretion, it may slightly increase the risk of bacterial infections in the gastrointestinal tract. If diarrhea persists, consultation with a physician is recommended. Long-term use, especially beyond one year, may increase the risk of fractures, so patients at risk for osteoporosis should have regular monitoring such as bone density tests. This medication may interact with other medications, so it should be taken as directed by a physician, especially in conjunction with anticoagulants, antiviral medications, antibiotics, and antidepressants. During pregnancy, the safety of this medication has not been fully confirmed, so it should only be used cautiously when necessary. It is recommended that nursing women not take this medication. In case of overdose, there is no specific antidote, so appropriate treatment should be sought based on symptoms. Finally, this medication should be kept out of reach of children and should not be transferred to another container, ensuring attention to the preservation of the medication's quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reactions, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reactions with eosinophilia and systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, substernal pain, facial edema, facial flushing, fatigue, flu-like symptoms, generalized edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue edema, ulcerative stomatitis, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, worsening arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disturbances, tremors, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, worsening asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, altered olfaction, loss of taste, taste distortion, urination abnormalities, albuminuria, cystitis, dysuria, fungal infections, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal strictures, esophageal ulcers, esophageal varices, gastric ulcers, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering. It should be kept at room temperature between 1°C and 30°C, away from extremely hot or cold environments.
Pink, oblong film-coated tablet
28 tablets/box [14 tablets/Alu-Alu*2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Il-Dong Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.